ArticleAmerican journal of translational research2026
Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer.
Lei Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.